Your session is about to expire
← Back to Search
Blood Flow Restriction Therapy for ACL Injury (ACLBONE Trial)
ACLBONE Trial Summary
This trial will investigate the effects of bone density on lower extremity loading mechanics, with the use of Blood Flow Restriction as a control group for bone health. The hypothesis is that the group with the restriction will have less bone mineral loss and improved functional performance.
ACLBONE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowACLBONE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ACLBONE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a cognitive impairment.I am an athlete who has had surgery to fix ligaments or cartilage.I am not an athlete aged 16-22.I am an athlete with a re-torn ACL or have had an ACL tear on the opposite knee.I am an athlete between 16 and 22 years old.I am an athlete getting ACL surgery, with or without meniscus issues.I am an athlete who has been advised not to put weight on a certain part of my body for more than 4 weeks.I cannot or do not want to complete my rehab at SportONE Parkview Fieldhouse.I do not have any systemic neuromuscular or balance disorders.You have used Blood Flow Restriction as an athlete in the past.
- Group 1: Delfi's PTS Personalized Tourniquet System for Blood Flow Restriction Group
- Group 2: Non Delfi PTS Personalized Tourniquet System for Blood Flow Restriction Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the criteria for enrolment in this research project?
"To be eligible to participate in this program, applicants must have suffered a tear of the anterior cruciate ligament and fall between 16 and 22 years old. The study is currently trying to enlist 60 participants in total."
Are there remaining openings for participants in this research endeavor?
"Affirmative. Clinicaltrials.gov states that the current recruitment effort, which was initially launched on February 17th 2021, is still ongoing. At this point in time, they are hoping to find 60 participants at a single medical centre."
Is there a maximum age limit for participants of this research project?
"This experimental research has an age range of 16 to 22. 47 studies were performed for youths under the legal age and 26 participants over 65 years old."
What is the maximum capacity for participants enrolled in this research endeavor?
"Affirmative. As per the details provided on clinicaltrials.gov, this investigation is currently searching for participants, having been first posted on February 17th 2021 and last updated September 1st 2022. The study requires 60 individuals at a single site to complete it."
Share this study with friends
Copy Link
Messenger